PDCD1 and Patent ductus arteriosus: The absence of co-stimulatory immune checkpoint receptors and PD-1 in more advanced PDA disease suggests hypo-responsive T cell phenotypes that may not be properly activated even when co-inhibitory checkpoints were blocked.